2003
DOI: 10.1074/jbc.m304890200
|View full text |Cite
|
Sign up to set email alerts
|

Targeted Disruption of Endothelial Cell-selective Adhesion Molecule Inhibits Angiogenic Processes in Vitro and in Vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
88
1
1

Year Published

2005
2005
2020
2020

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 102 publications
(95 citation statements)
references
References 43 publications
(35 reference statements)
5
88
1
1
Order By: Relevance
“…37 A recently identified TJ protein, ESAM, however, has been found to promote in vitro tube formation in endothelial-like yolk sac cells and the genetic ablation of ESAM leads to decreased tumor size and vascularization. 16 These findings indicate that TJs might offer a new frontier for the regulation of angiogenesis. Our finding of the role of JAM-A in FGF-2-induced neovascularization is the second record to demonstrate an involvement of a TJ protein in angiogenesis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…37 A recently identified TJ protein, ESAM, however, has been found to promote in vitro tube formation in endothelial-like yolk sac cells and the genetic ablation of ESAM leads to decreased tumor size and vascularization. 16 These findings indicate that TJs might offer a new frontier for the regulation of angiogenesis. Our finding of the role of JAM-A in FGF-2-induced neovascularization is the second record to demonstrate an involvement of a TJ protein in angiogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…16 Briefly, 1 mL of phosphate-buffered saline containing 25 mg of 2ϫ10 6 molecular weight FITC-dextran was injected into the portal vein. Thirty minutes later, mice were euthanized by CO 2 asphyxiation; the eyes were removed and fixed in 4% paraformaldehyde in phosphate-buffered saline for 3 hours.…”
Section: Retinal Fluorescein Angiogrammentioning
confidence: 99%
“…The congenic C57BL/6 strain (C57BL/ 6SJL; CD45.1 alloantigen) was purchased from The Jackson Laboratory (Bar Harbor, ME) and used for transplantation experiments. ESAM KO mice were developed by Dr. T. Ishida (Kobe University, Kobe, Japan) as previously reported (18). Mating of heterozygous male and female mice was routinely performed to generate homozygous ESAM KO mice.…”
Section: Micementioning
confidence: 99%
“…Claudins (Furuse et al, 1998), (Furuse et al, 2002), (Nitta et al, 2003), (Turksen and Troy, 2002), (Tatum et al, 2010), (Nakano et al, 2009), (Gow et al, 1999), (Gow et al, 2004), (Ben-Yosef et al, 2003), (Tamura et al, 2008), (Simon et al, 1999), (Miyamoto et al, 2005), (Hou et al, 2009), (Angelow et al, 2008) Occludin (Furuse et al, 1993), (Traweger et al, 2002), (Sakakibara et al, 1997), (Saitou et al, 2000), (Furuse et al, 1998), (Du et al, 2010), (Runkle et al, 2011) MarvelD3 (Raleigh et al, 2010), (Steed et al, 2009) Tricellulin (Ikenouchi et al, 2005), (Ikenouchi et al, 2008) LSR (Masuda et al, 2011) JAMs (Hirabayashi and Hata, 2006), (Weber et al, 2007), (Kostrewa et al, 2001), (Laukoetter et al, 2007), (Pellegrini et al, 2011), (Ishida et al, 2003) …”
Section: Recommended Readingmentioning
confidence: 99%